Last reviewed · How we verify
Sensitizing DPCP Ointment — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Sensitizing DPCP Ointment (Sensitizing DPCP Ointment) — RXi Pharmaceuticals, Corp..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Sensitizing DPCP Ointment TARGET | Sensitizing DPCP Ointment | RXi Pharmaceuticals, Corp. | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Sensitizing DPCP Ointment CI watch — RSS
- Sensitizing DPCP Ointment CI watch — Atom
- Sensitizing DPCP Ointment CI watch — JSON
- Sensitizing DPCP Ointment alone — RSS
Cite this brief
Drug Landscape (2026). Sensitizing DPCP Ointment — Competitive Intelligence Brief. https://druglandscape.com/ci/sensitizing-dpcp-ointment. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab